Why is Ajooni Biotech falling/rising?

As of 05-Sep, Ajooni Biotech Ltd is experiencing a decline in its stock price, currently at Rs 5.21, reflecting a decrease of Rs 0.03 or 0.57%. The stock has underperformed its sector by 0.5% today and is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock is close to its 52-week low, being only 3.84% away from Rs 5.01. Over the past week, the stock has dropped by 3.34%, and its year-to-date performance shows a significant decline of 32.95%. Despite positive results in the last four quarters, including a 67.58% growth in PAT and higher net sales, the stock's long-term fundamentals are weak, with a poor return on capital employed and a low EBIT to interest ratio.
In the broader market context, Ajooni Biotech's recent performance contrasts sharply with the Sensex, which has gained 1.29% over the past week. The stock has consistently underperformed against the benchmark, showing a 49.61% decline over the past year compared to a slight drop of 1.61% for the Sensex. This underperformance is compounded by falling investor participation, as indicated by an 11.85% decrease in delivery volume against the 5-day average. While the stock is trading at a discount compared to its peers, the weak long-term growth prospects and inability to service debt effectively contribute to its downward trajectory.